In the case of CNS disorders, insulin resistance is predisposed to the pathophysiology of various neurological disorders, where depression-induced chronic stress increases the release of corticotropin-releasing factor (CRF) and activates the hypothalamus-pituitary axis (HPA) which elevates glucocorticoid levels. Here, CRH is linked to depressive symptom measurement.